Rima Arnaout, MD
Cardiovascular Disease (Cardiology) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 5
- Since medical school
- 19 years
- Harvard Medical School, 2007
Offices
5 locations · Regents of the University of California · University of California San Francisco
Looking this up.
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Arnaout’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$29,786
Medicare paid this office $29,786 for 428 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 254 | $14,900 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $7,016 | $88 |
| Ultrasound of heart with probe in esophagus, with report | 25 | $2,328 | $93 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 14 | $947 | $68 |
| Ultrasound of heart, follow-up | 28 | $679 | $22 |
See all 11 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 254 | $14,900 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 80 | $7,016 | $88 |
| Ultrasound of heart with probe in esophagus, with report | 25 | $2,328 | $93 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 14 | $947 | $68 |
| Ultrasound of heart, follow-up | 28 | $679 | $22 |
| Heart muscle strain imaging | 65 | $610 | $9 |
| Ultrasound of heart blood flow, valves and chambers | 26 | $408 | $16 |
| Heart muscle strain imaging | 13 | $301 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $300 | $19 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 32 | $211 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 57 | $163 | $3 |
Who their Medicare patients are
428 Original Medicare patients in 2024. Average age 75 · Under 65 10% · 85 and older 12% · Women 49% · Also on Medicaid 33% · Health risk score 2.26. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 45% · Heart failure 43% · Chronic kidney disease 43% · Atrial fibrillation 40% · Diabetes 39% · Depression 26% · Cancer 22% · Stroke 20% · COPD 18% · Dementia 13%.
The office billed $571,723, Medicare allowed $39,316 and paid $29,786; for 656 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 428 | 656 | 75 | 2.26 | $571,723 | $29,786 |
| 2023 | 427 | 748 | 74 | 2.54 | $615,072 | $39,663 |
| 2022 | 392 | 639 | 74 | 2.33 | $552,477 | $33,306 |
| 2021 | 409 | 604 | 73 | 2.29 | $535,681 | $29,561 |
| 2020 | 325 | 481 | 71 | 2.56 | $366,704 | $26,378 |
| 2019 | 384 | 581 | 72 | 2.25 | $406,747 | $34,185 |
| 2018 | 365 | 611 | 72 | 2.33 | $372,215 | $42,485 |
| 2017 | 289 | 502 | 72 | 2.76 | $294,604 | $34,272 |
| 2016 | 310 | 465 | 71 | 2.48 | $280,560 | $26,986 |
| 2015 | 304 | 441 | 69 | 2.14 | $261,207 | $26,127 |
| 2014 | 302 | 511 | 71 | 2.31 | $290,691 | $36,152 |
| 2013 | 15 | 31 | 74 | 2.23 | $13,104 | $2,975 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 254 | $15,271 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $6,603 | $107 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 52 | $6,113 | $115 |
| Ultrasound of heart with probe in esophagus, with report | 24 | $2,211 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,285 | $71 |
| Hospital discharge day management, 30 minutes or less | 17 | $1,261 | $74 |
| Ultrasound of heart, follow-up | 40 | $913 | $22 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $889 | $74 |
| Heart muscle strain imaging | 53 | $528 | $10 |
| Heart muscle strain imaging | 13 | $388 | $30 |
| Ultrasound of heart blood flow, valves and chambers | 23 | $367 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $267 | $19 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 40 | $259 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 64 | $180 | $3 |
2022: 13 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 247 | $14,562 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $8,245 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 36 | $2,296 | $64 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,436 | $90 |
| Hospital discharge day management, 30 minutes or less | 15 | $979 | $65 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $975 | $75 |
| Ultrasound of heart, follow-up | 30 | $695 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $367 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $252 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $246 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 32 | $210 | $6 |
| Heart muscle strain imaging | 16 | $158 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 48 | $136 | $3 |
2021: 13 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 287 | $16,997 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $3,184 | $86 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $1,987 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 27 | $1,639 | $61 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $839 | $76 |
| Hospital discharge day management, 30 minutes or less | 11 | $722 | $66 |
| Ultrasound of heart, follow-up | 26 | $617 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 23 | $434 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $344 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 23 | $291 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 27 | $182 | $7 |
| Heart muscle strain imaging | 14 | $151 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 47 | $137 | $3 |
2020: 10 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 219 | $13,828 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $3,319 | $95 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 23 | $1,585 | $69 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 21 | $1,340 | $64 |
| Hospital discharge day management, 30 minutes or less | 11 | $758 | $69 |
| Ultrasound of heart, follow-up | 24 | $658 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $285 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $191 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 24 | $180 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 32 | $102 | $3 |
2019: 13 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 244 | $15,851 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $7,473 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,996 | $181 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $1,760 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 27 | $1,758 | $65 |
| Hospital discharge day management, 30 minutes or less | 16 | $1,061 | $66 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 15 | $910 | $61 |
| Ultrasound of heart, follow-up | 20 | $468 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $384 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $302 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $257 | $14 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 22 | $146 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 40 | $120 | $3 |
2018: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $13,217 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 207 | $13,075 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,844 | $177 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 38 | $2,336 | $61 |
| Hospital discharge day management, 30 minutes or less | 31 | $2,048 | $66 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 21 | $417 | $20 |
| Ultrasound of heart, follow-up | 13 | $323 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $280 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 11 | $78 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $57 | $3 |
2017: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $11,379 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 170 | $9,410 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,110 | $176 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,322 | $66 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $633 | $58 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 20 | $392 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 20 | $268 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $83 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 15 | $43 | $3 |
2016: 10 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 213 | $11,793 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $4,335 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,022 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,217 | $64 |
| Hospital discharge day management, 30 minutes or less | 11 | $722 | $66 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 13 | $597 | $46 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 11 | $572 | $52 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 28 | $513 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 28 | $346 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $41 | $3 |
2015: 7 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 199 | $11,095 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $5,351 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,191 | $183 |
| New patient visit (60+ min) | 12 | $1,814 | $151 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 30 | $521 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 30 | $394 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 11 | $33 | $3 |
2014: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $11,626 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 164 | $8,946 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 37 | $6,685 | $181 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,252 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $1,009 | $92 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 16 | $849 | $53 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 26 | $487 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 28 | $343 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 15 | $114 | $7 |
Medicaid work
$11,176 in 2024
Medicaid paid $11,176 for 103 billed services this clinician did in 2024, up to 29 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 91 | $10,819 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 12 | $357 |
| 2024 | 103 | 2 | 29 | $11,176 |
| 2023 | 166 | 2 | 30 | $13,713 |
| 2022 | 153 | 1 | 35 | $13,380 |
| 2021 | 135 | 1 | 27 | $10,860 |
| 2020 | 82 | 1 | 15 | $6,881 |
| 2019 | 95 | 1 | 23 | $6,578 |
| 2018 | 30 | 1 | 17 | $2,276 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 151 | $13,668 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 15 | $46 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 153 | $13,380 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 135 | $10,860 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 82 | $6,881 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 95 | $6,578 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 30 | $2,276 |
Drugs they prescribed that Part D paid
$11,980
Pharmacies billed $11,980 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 31) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
22 generic and fewer than 11 brand-name prescriptions · $11,980 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 31 | None | 0% (0) | None | $11,980 |
| 2023 | 100 | 19 | 0% (0) | 24% | $20,396 |
| 2022 | 27 | None | 0% (0) | None | $2,475 |
| 2021 | 13 | None | 0% (0) | None | $1,857 |
| 2020 | 63 | 12 | 0% (0) | 44% | $12,680 |
| 2019 | 122 | 25 | None | 29% | $11,438 |
| 2018 | 181 | 42 | 0% (0) | 12% | $25,865 |
| 2017 | 134 | 29 | 0% (0) | None | $8,808 |
| 2016 | 61 | 15 | 0% (0) | None | $1,792 |
| 2015 | 69 | 19 | None | None | $1,300 |
| 2014 | 131 | 31 | 0% (0) | 23% | $6,690 |
| 2013 | 14 | None | 0% (0) | None | $868 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Metoprolol | 11 | $217 | $20 |
2019: 2 drugs
| Metoprolol | 18 | $449 | $25 |
| Atorvastatin | 19 | $359 | $19 |
2018: 6 drugs
| Clopidogrel | 31 | $376 | $12 |
| Atorvastatin | 17 | $341 | $20 |
| Metoprolol | 13 | $288 | $22 |
| Carvedilol | 15 | $111 | $7 |
| Furosemide | 11 | $32 | $3 |
| Lisinopril | 14 | $24 | $2 |
2017: 3 drugs
| Ampicillin | 14 | $2,285 | $163 |
| Ceftriaxone | 14 | $314 | $22 |
| Clopidogrel | 15 | $135 | $9 |
2016: 1 drug
| Atorvastatin | 11 | $120 | $11 |
2015: 1 drug
| Metoprolol | 17 | $193 | $11 |
2014: 3 drugs
| Metoprolol | 23 | $431 | $19 |
| Amlodipine Besylate | 15 | $84 | $6 |
| Furosemide | 13 | $50 | $4 |
Money from drug and device companies
$80 in 2019
A payment is not proof that care is biased.
| AtriCure | Atricure Atriclip Laa Exclusion | $62 | 1 payment
|
| Siemens Medical Solutions USA | Sc2000 | $18 | 1 payment
|
See all 2 published payments
| Siemens Medical Solutions USA | Meals · 2019-05-24 | Sc2000 | $18 |
| AtriCure | Meals · 2019-03-16 | Atricure Atriclip Laa Exclusion | $62 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1871798470
- Licence
- MA L-232279
- Trained
- Harvard Medical School, 2007 · 19 years ago
- Group
- Regents of the University of California · University of California San Francisco
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 521 Parnassus Ave Rm 6222, San Francisco, CA, 94143
- NPI first listed
- 2007-06-15
- NPI last updated
- 2025-12-04
- NPI record certified
- 2025-12-04
This is when the NPI record was last certified, not a medical board exam.